Humana Inc. (HUM) Reaches New 1-Year High After Better-Than-Expected Earnings
Shares of Humana Inc. (NYSE:HUM) hit a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $246.15 and last traded at $246.45, with a volume of 1,418,584 shares changing hands. The stock had previously closed at $241.09.
The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter in the previous year, the company posted $2.30 earnings per share.
Several equities research analysts recently weighed in on HUM shares. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Monday, April 24th. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price objective on shares of Humana in a report on Friday, July 14th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $223.00 price objective (up previously from $200.00) on shares of Humana in a report on Thursday. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $246.00 price objective on shares of Humana in a report on Friday, July 14th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a $250.00 price objective (up previously from $245.00) on shares of Humana in a report on Thursday, July 13th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $240.30.
In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the sale, the senior vice president now owns 14,258 shares in the company, valued at approximately $3,421,920. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction dated Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the sale, the vice president now owns 8,150 shares in the company, valued at approximately $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by insiders.
A number of hedge funds have recently bought and sold shares of the company. Baldwin Brothers Inc. MA increased its stake in Humana by 2.7% in the first quarter. Baldwin Brothers Inc. MA now owns 67,441 shares of the insurance provider’s stock valued at $13,902,000 after buying an additional 1,782 shares during the last quarter. ProShare Advisors LLC increased its stake in Humana by 15.8% in the first quarter. ProShare Advisors LLC now owns 17,297 shares of the insurance provider’s stock valued at $3,566,000 after buying an additional 2,356 shares during the last quarter. Capstone Asset Management Co. increased its stake in Humana by 2.0% in the first quarter. Capstone Asset Management Co. now owns 16,805 shares of the insurance provider’s stock valued at $3,464,000 after buying an additional 334 shares during the last quarter. Granite Investment Advisors LLC increased its stake in Humana by 12.1% in the first quarter. Granite Investment Advisors LLC now owns 2,410 shares of the insurance provider’s stock valued at $497,000 after buying an additional 260 shares during the last quarter. Finally, CHURCHILL MANAGEMENT Corp bought a new stake in Humana during the second quarter valued at about $6,074,000. Hedge funds and other institutional investors own 99.62% of the company’s stock.
The stock has a 50 day moving average of $236.19 and a 200-day moving average of $220.68. The company has a market cap of $35.54 billion, a PE ratio of 20.23 and a beta of 0.91.
TRADEMARK VIOLATION NOTICE: This news story was published by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/08/05/humana-inc-hum-reaches-new-1-year-high-after-better-than-expected-earnings.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.